During the recent session, Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s traded shares were 6.41 million, with the beta value of the company hitting 1.01. The 52-week high for the CNSP share is $65.00, that puts it down -54066.67 from that peak though still a striking 16.67% gain since the share price plummeted to a 52-week low of $0.10. The company’s market capitalization is $7.00M, and the average intraday trading volume over the past 10 days was 7.14 million shares, and the average trade volume was 16.16 million shares over the past three months.

Cns Pharmaceuticals Inc (NASDAQ:CNSP) trade information

Cns Pharmaceuticals Inc (CNSP) registered a 1.16% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 1.16% in intraday trading to $0.12, hitting a weekly high. The stock’s 5-day price performance is 11.74%, and it has moved by 8.85% in 30 days. Based on these gigs, the overall price performance for the year is -99.80%. The short interest in Cns Pharmaceuticals Inc (NASDAQ:CNSP) is 1.14 million shares and it means that shorts have 0.04 day(s) to cover.

The consensus price target of analysts on Wall Street is $0.5, which implies an increase of 76.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $0.5 and $0.5 respectively. As a result, CNSP is trading at a discount of -316.67% off the target high and -316.67% off the low.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 17.98%.

CNSP Dividends

Cns Pharmaceuticals Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s Major holders

Cns Pharmaceuticals Inc insiders own 1.04% of total outstanding shares while institutional holders control 0.79%, with the float percentage being 0.80%.